Indication

Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis

Anti-acetylcholine receptor antibody positive generalized myasthenia gravis is a chronic autoimmune disorder affecting the neuromuscular junction across the peripheral nervous and muscular systems. Read more about Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis

7 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis therapies.

Showing 1–7 of 7 drugs

ZILBRYSQ (zilucoplan sodium)

COMPLEMENT INHIBITORS·ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE GENERALIZED MYASTHENIA GRAVIS
UCB, Inc.

UPLIZNA (inebilizumab-cdon)

ANTINEOPLASTIC MONOCLONAL ANTIBODIES·NEUROMYELITIS OPTICA SPECTRUM DISORDER WITH ANTI-AQUAPORIN-4 (AQP4) ANTIBODIES·+3
HORIZON/AMGEN
Filter & compare in the drug finder →Opens the drug finder with Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis.

Anti-acetylcholine receptor antibody positive generalized myasthenia gravis is a chronic autoimmune disorder affecting the neuromuscular junction across the peripheral nervous and muscular systems.

It is pathophysiologically defined by circulating pathogenic autoantibodies directed against nicotinic acetylcholine receptors on the postsynaptic muscle endplate, precipitating receptor blockade, internalization, and complement-mediated destruction of the neuromuscular junction.

Clinically, it presents with fluctuating, fatigable skeletal muscle weakness extending beyond the ocular musculature to involve bulbar, limb, neck, and respiratory muscles, with symptoms typically worsening after sustained exertion.

Personalize your experience

Follow Anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it